- 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
- 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
- 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
- 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
- 如果EPS衰退，要觀察同業是不是有一樣的狀況
- 要留意增資減資和公司債對股本及EPS的影響
| 加權平均股數 QoQ YoY | EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | 營收 QoQ YoY | 毛利率(%) QoQ YoY | 營業利益 QoQ YoY | 稅後淨利 QoQ YoY | 稅前淨利率(%) QoQ YoY | 稅後淨利率(%) QoQ YoY | 兩季平均(YOY)營收成長率(%) | 兩季平均(YOY)EPS成長率(%) | 兩季平均(YOY)本業EPS成長率(%) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23Q4 (20) | 970 | 0.0 | 0.0 | -0.17 | -1800.0 | -112.5 | 0.05 | 600.0 | -87.18 | -0.51 | -50.0 | -172.86 | 44.48 | -5.64 | -20.83 | 8.81 | 6.53 | -28.02 | 1.52 | 157.63 | -45.13 | -1.62 | -1900.0 | -105.06 | -1.27 | -176.51 | 61.52 | -3.79 | -18850.0 | 1.04 | 5.02 | -848.65 | 348.72 |
| 23Q3 (19) | 970 | 0.0 | 0.0 | 0.01 | 102.7 | -98.25 | -0.01 | 97.44 | -101.85 | -0.34 | 2.86 | -143.59 | 47.14 | 15.68 | -29.57 | 8.27 | 407.36 | -53.2 | 0.59 | 117.2 | -92.9 | 0.09 | 102.49 | -98.36 | 1.66 | 120.67 | -87.1 | -0.02 | 99.79 | -100.23 | 1.76 | -923.65 | -163.78 |
| 23Q2 (18) | 970 | 0.0 | 0.0 | -0.37 | -1950.0 | 0 | -0.39 | -425.0 | -333.33 | -0.35 | -1850.0 | -266.67 | 40.75 | -12.16 | -30.28 | 1.63 | -87.75 | -85.43 | -3.43 | -221.2 | -223.83 | -3.62 | -1823.81 | -7140.0 | -8.03 | -294.9 | -230.57 | -9.69 | -2161.7 | -1715.0 | -14.79 | -912.50 | -247.12 |
| 23Q1 (17) | 970 | 0.0 | 0.0 | 0.02 | 125.0 | -90.91 | 0.12 | -69.23 | -14.29 | 0.02 | -97.14 | -90.91 | 46.39 | -17.43 | -10.98 | 13.31 | 8.74 | -7.31 | 2.83 | 2.17 | -20.28 | 0.21 | 126.58 | -90.14 | 4.12 | 224.85 | -50.84 | 0.47 | 112.27 | -90.37 | -16.74 | 5.48 | -48.51 |
| 22Q4 (16) | 970 | 0.0 | 0.0 | -0.08 | -114.04 | -103.83 | 0.39 | -27.78 | -81.94 | 0.70 | -10.26 | -80.0 | 56.18 | -16.06 | -29.34 | 12.24 | -30.73 | -73.72 | 2.77 | -66.67 | -92.26 | -0.79 | -114.36 | -103.9 | -3.30 | -125.64 | -107.48 | -3.83 | -143.52 | -114.98 | -0.77 | -57.02 | 336.11 |
| 22Q3 (15) | 970 | 0.0 | 0.0 | 0.57 | 0 | -14.93 | 0.54 | 700.0 | 5.88 | 0.78 | 271.43 | -44.68 | 66.93 | 14.51 | 23.49 | 17.67 | 57.91 | -6.75 | 8.31 | 200.0 | 46.05 | 5.5 | 11100.0 | -14.86 | 12.87 | 109.27 | -3.81 | 8.80 | 1366.67 | -27.75 | 13.34 | -50.00 | 267.86 |
| 22Q2 (14) | 970 | 0.0 | 0.0 | 0.00 | -100.0 | -100.0 | -0.09 | -164.29 | -147.37 | 0.21 | -4.55 | -72.0 | 58.45 | 12.17 | -0.65 | 11.19 | -22.08 | -38.21 | 2.77 | -21.97 | -32.77 | -0.05 | -102.35 | -101.69 | 6.15 | -26.61 | -31.36 | 0.60 | -87.7 | -89.58 | -11.14 | -94.73 | -128.91 |
| 22Q1 (13) | 970 | 0.0 | 0.0 | 0.22 | -89.47 | -50.0 | 0.14 | -93.52 | -69.57 | 0.22 | -93.71 | -50.0 | 52.11 | -34.46 | -2.85 | 14.36 | -69.16 | -32.96 | 3.55 | -90.09 | -42.18 | 2.13 | -89.49 | -50.35 | 8.38 | -81.01 | -24.5 | 4.88 | -80.92 | -34.5 | 6.12 | 61.23 | 115.00 |
| 21Q4 (12) | 970 | 0.0 | 0.0 | 2.09 | 211.94 | 309.8 | 2.16 | 323.53 | 285.71 | 3.50 | 148.23 | 366.67 | 79.51 | 46.7 | 61.67 | 46.57 | 145.75 | 87.78 | 35.81 | 529.35 | 389.21 | 20.26 | 213.62 | 312.63 | 44.12 | 229.75 | 217.18 | 25.57 | 109.93 | 142.14 | 19.42 | 167.63 | 245.97 |
| 21Q3 (11) | 970 | 0.0 | 0.0 | 0.67 | 123.33 | 28.85 | 0.51 | 168.42 | -7.27 | 1.41 | 88.0 | 487.5 | 54.2 | -7.87 | 10.52 | 18.95 | 4.64 | -27.89 | 5.69 | 38.11 | -23.62 | 6.46 | 118.98 | 28.43 | 13.38 | 49.33 | -8.54 | 12.18 | 111.46 | 11.54 | 0.90 | 45.75 | 54.86 |
| 21Q2 (10) | 970 | 0.0 | -1.82 | 0.30 | -31.82 | 230.43 | 0.19 | -58.7 | 173.08 | 0.75 | 70.45 | 377.78 | 58.83 | 9.68 | 108.84 | 18.11 | -15.45 | 34.65 | 4.12 | -32.9 | 405.19 | 2.95 | -31.24 | 229.96 | 8.96 | -19.28 | 332.73 | 5.76 | -22.68 | 153.33 | 9.38 | -22.77 | -38.28 |
| 21Q1 (9) | 970 | 0.0 | 0.0 | 0.44 | -13.73 | 1200.0 | 0.46 | -17.86 | 483.33 | 0.44 | -41.33 | 1200.0 | 53.64 | 9.07 | 20.11 | 21.42 | -13.63 | 46.71 | 6.14 | -16.12 | 940.68 | 4.29 | -12.63 | 1172.5 | 11.10 | -20.2 | 277.55 | 7.45 | -29.45 | 543.45 | 4.68 | -7.83 | -8.02 |
| 20Q4 (8) | 970 | 0.0 | 0.0 | 0.51 | -1.92 | 234.21 | 0.56 | 1.82 | 286.67 | 0.75 | 212.5 | -37.5 | 49.18 | 0.29 | 37.49 | 24.80 | -5.63 | 281.02 | 7.32 | -1.74 | 324.54 | 4.91 | -2.39 | 233.06 | 13.91 | -4.92 | 222.34 | 10.56 | -3.3 | 180.61 | 37.19 | 162.08 | 156.68 |
| 20Q3 (7) | 970 | -1.82 | 0.0 | 0.52 | 326.09 | -1.89 | 0.55 | 311.54 | 7.84 | 0.24 | 188.89 | -84.81 | 49.04 | 74.09 | -23.54 | 26.28 | 95.39 | -12.4 | 7.45 | 651.85 | -9.7 | 5.03 | 321.59 | -2.14 | 14.63 | 480.0 | 11.34 | 10.92 | 201.11 | 27.87 | 18.59 | -74.46 | 97.44 |
| 20Q2 (6) | 988 | 1.86 | 15.15 | -0.23 | -475.0 | -174.19 | -0.26 | -116.67 | -204.0 | -0.27 | -575.0 | -122.69 | 28.17 | -36.92 | -54.65 | 13.45 | -7.88 | -36.47 | -1.35 | -328.81 | -124.68 | -2.27 | -467.5 | -184.7 | -3.85 | -230.95 | -141.53 | -10.80 | -542.86 | -326.42 | -6.04 | -192.76 | -28.34 |
| 20Q1 (5) | 970 | 0.0 | 13.05 | -0.04 | 89.47 | -104.55 | -0.12 | 60.0 | -115.0 | -0.04 | -103.33 | -104.55 | 44.66 | 24.85 | -26.41 | 14.60 | 206.57 | -43.87 | 0.59 | 118.1 | -94.61 | -0.4 | 89.16 | -105.3 | 2.94 | 125.86 | -83.45 | -1.68 | 87.18 | -112.9 | - | - | 0.00 |
| 19Q4 (4) | 970 | 0.0 | 0.0 | -0.38 | -171.7 | 0.0 | -0.30 | -158.82 | 0.0 | 1.20 | -24.05 | 0.0 | 35.77 | -44.23 | 0.0 | -13.70 | -145.67 | 0.0 | -3.26 | -139.52 | 0.0 | -3.69 | -171.79 | 0.0 | -11.37 | -186.53 | 0.0 | -13.10 | -253.4 | 0.0 | - | - | 0.00 |
| 19Q3 (3) | 970 | 13.05 | 0.0 | 0.53 | 70.97 | 0.0 | 0.51 | 104.0 | 0.0 | 1.58 | 32.77 | 0.0 | 64.14 | 3.25 | 0.0 | 30.00 | 41.71 | 0.0 | 8.25 | 50.82 | 0.0 | 5.14 | 91.79 | 0.0 | 13.14 | 41.75 | 0.0 | 8.54 | 79.04 | 0.0 | - | - | 0.00 |
| 19Q2 (2) | 858 | 0.0 | 0.0 | 0.31 | -64.77 | 0.0 | 0.25 | -68.75 | 0.0 | 1.19 | 35.23 | 0.0 | 62.12 | 2.36 | 0.0 | 21.17 | -18.61 | 0.0 | 5.47 | -50.05 | 0.0 | 2.68 | -64.5 | 0.0 | 9.27 | -47.8 | 0.0 | 4.77 | -63.36 | 0.0 | - | - | 0.00 |
| 19Q1 (1) | 858 | 0.0 | 0.0 | 0.88 | 0.0 | 0.0 | 0.80 | 0.0 | 0.0 | 0.88 | 0.0 | 0.0 | 60.69 | 0.0 | 0.0 | 26.01 | 0.0 | 0.0 | 10.95 | 0.0 | 0.0 | 7.55 | 0.0 | 0.0 | 17.76 | 0.0 | 0.0 | 13.02 | 0.0 | 0.0 | - | - | 0.00 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/3 | 14.45 | 5.93 | -5.06 | 44.23 | -4.65 | 44.23 | N/A | - | ||
| 2024/2 | 13.64 | -15.49 | -14.58 | 29.78 | -4.45 | 42.37 | N/A | - | ||
| 2024/1 | 16.14 | 28.27 | 6.18 | 16.14 | 6.18 | 43.39 | N/A | - | ||
| 2023/12 | 12.58 | -14.2 | -21.15 | 178.77 | -23.44 | 44.49 | 0.62 | - | ||
| 2023/11 | 14.67 | -14.9 | -16.63 | 166.18 | -23.61 | 47.77 | 0.58 | - | ||
| 2023/10 | 17.24 | 8.63 | -23.22 | 151.51 | -24.22 | 48.74 | 0.57 | - | ||
| 2023/9 | 15.87 | 1.46 | -25.41 | 134.28 | -24.35 | 47.12 | 0.56 | - | ||
| 2023/8 | 15.64 | 0.09 | -29.43 | 118.41 | -24.2 | 43.26 | 0.61 | - | ||
| 2023/7 | 15.62 | 30.17 | -33.53 | 102.78 | -23.34 | 42.25 | 0.63 | - | ||
| 2023/6 | 12.0 | -17.97 | -37.1 | 87.15 | -21.17 | 40.76 | 0.72 | - | ||
| 2023/5 | 14.63 | 3.54 | -25.59 | 75.15 | -17.85 | 43.98 | 0.67 | - | ||
| 2023/4 | 14.13 | -7.17 | -28.3 | 60.52 | -15.73 | 45.32 | 0.65 | - | ||
| 2023/3 | 15.22 | -4.69 | -15.99 | 46.39 | -10.97 | 46.39 | 0.71 | - | ||
| 2023/2 | 15.97 | 5.06 | 3.35 | 31.17 | -8.3 | 47.13 | 0.7 | - | ||
| 2023/1 | 15.2 | -4.75 | -18.02 | 15.2 | -18.02 | 48.76 | 0.68 | - | ||
| 2022/12 | 15.96 | -9.28 | 21.86 | 233.51 | -5.21 | 56.01 | 0.57 | - | ||
| 2022/11 | 17.59 | -21.63 | -62.88 | 217.55 | -6.73 | 61.32 | 0.52 | 2021年11月與Genzyme 就被授權之歐洲及美國專利權所生之歐洲與美國權利金爭議達成和解，故於2021年11月認列權利金收入。 | ||
| 2022/10 | 22.45 | 5.54 | 34.31 | 199.95 | 7.58 | 65.88 | 0.49 | - | ||
| 2022/9 | 21.27 | -4.0 | 32.08 | 177.5 | 4.94 | 66.93 | 0.54 | - | ||
| 2022/8 | 22.16 | -5.71 | 1.17 | 156.23 | 2.08 | 64.74 | 0.56 | - | ||
| 2022/7 | 23.5 | 23.18 | 25.86 | 134.07 | 2.23 | 62.25 | 0.58 | - | ||
| 2022/6 | 19.08 | -2.97 | -2.4 | 110.57 | -1.68 | 58.45 | 0.57 | - | ||
| 2022/5 | 19.66 | -0.23 | 3.72 | 91.49 | -1.53 | 57.49 | 0.58 | - | ||
| 2022/4 | 19.71 | 8.78 | -2.84 | 71.82 | -2.88 | 53.28 | 0.63 | - | ||
| 2022/3 | 18.12 | 17.25 | -3.36 | 52.11 | -2.89 | 52.11 | 0.59 | - | ||
| 2022/2 | 15.45 | -16.67 | -1.72 | 34.0 | -2.64 | 47.09 | 0.66 | - | ||
| 2022/1 | 18.54 | 41.58 | -3.4 | 18.54 | -3.4 | 79.04 | 0.39 | - | ||
| 2021/12 | 13.1 | -72.36 | -26.33 | 246.35 | 43.86 | 77.21 | 0.36 | - | ||
| 2021/11 | 47.4 | 183.55 | 191.69 | 233.26 | 52.0 | 80.22 | 0.35 | 與Genzyme 就被授權之歐洲及美國專利權所生之歐洲與美國權利金爭議達成和解，故本月認列權利金收入。 | ||
| 2021/10 | 16.72 | 3.79 | 8.93 | 185.86 | 35.45 | 54.72 | 0.51 | - | ||
| 2021/9 | 16.1 | -26.46 | 3.94 | 169.14 | 38.79 | 56.68 | 0.41 | - | ||
| 2021/8 | 21.9 | 17.28 | 14.72 | 153.04 | 43.87 | 60.12 | 0.39 | - | ||
| 2021/7 | 18.67 | -4.47 | 27.85 | 131.14 | 50.24 | 57.18 | 0.41 | 109年受到疫情影響停工，銷量減少，110年疫情趨緩，銷量增加，致營收增加。 | ||
| 2021/6 | 19.55 | 3.12 | 66.33 | 112.46 | 54.74 | 58.79 | 0.35 | 109年因疫情影響，營收減少，110年因疫情趨緩，營收增加 | ||
| 2021/5 | 18.96 | -6.54 | 109.32 | 92.91 | 52.51 | 57.99 | 0.36 | 109年因疫情影響，營收減少，110年因疫情趨緩，營收增加 | ||
| 2021/4 | 20.29 | 8.2 | 181.42 | 73.96 | 42.59 | 54.76 | 0.38 | 109年受到疫情影響停工，銷量減少，110年疫情趨緩，銷量增加，致營收增加。 | ||
| 2021/3 | 18.75 | 19.24 | 22.78 | 53.67 | 20.18 | 53.67 | 0.53 | - | ||
| 2021/2 | 15.72 | -18.1 | 7.06 | 34.92 | 18.82 | 52.7 | 0.54 | - | ||
| 2021/1 | 19.2 | 7.98 | 30.57 | 19.2 | 30.57 | 53.23 | 0.54 | - | ||
| 2020/12 | 17.78 | 9.41 | 903.0 | 171.24 | -23.11 | 49.37 | 0.45 | 本月營收較同期增加，係108年12月當期調減108年第2季到第4季未收到之權利金收入所致。 | ||
| 2020/11 | 16.25 | 5.89 | -2.59 | 153.46 | -30.54 | 47.09 | 0.47 | - | ||
| 2020/10 | 15.34 | -0.95 | -11.36 | 137.21 | -32.82 | 49.93 | 0.44 | - | ||
| 2020/9 | 15.49 | -18.84 | -17.91 | 121.86 | -34.81 | 49.19 | 0.47 | - | ||
| 2020/8 | 19.09 | 30.7 | -20.95 | 106.37 | -36.71 | 45.45 | 0.51 | - | ||
| 2020/7 | 14.61 | 24.26 | -30.81 | 87.28 | -39.35 | 35.41 | 0.65 | - | ||
| 2020/6 | 11.75 | 29.77 | -41.88 | 72.67 | -40.82 | 28.02 | 1.0 | - | ||
| 2020/5 | 9.06 | 25.63 | -57.3 | 60.92 | -40.61 | 31.53 | 0.89 | 營收較去年同期減少，係因受到疫情影響，銷量減少所致 | ||
| 2020/4 | 7.21 | -52.79 | -65.14 | 51.87 | -36.26 | 37.16 | 0.75 | 營收較上期、去年同期減少，係因受疫情停工影響，銷量減少，以致營收減少 | ||
| 2020/3 | 15.27 | 3.97 | -27.21 | 44.66 | -26.41 | 44.66 | 0.66 | - | ||
| 2020/2 | 14.69 | -0.11 | -18.56 | 29.39 | -25.99 | 31.16 | 0.95 | - | ||
| 2020/1 | 14.7 | 729.44 | -32.18 | 14.7 | -32.18 | 33.16 | 0.89 | - | ||
| 2019/12 | 1.77 | -89.37 | -90.96 | 222.71 | -8.83 | 35.77 | 0.83 | 係原合併營收公告數與會計師查核數差異，請參閱109/3/20序號5重訊之說明 | ||
| 2019/11 | 16.68 | -3.63 | -19.07 | 220.94 | -1.66 | 52.87 | 0.56 | - | ||
| 2019/10 | 17.31 | -8.28 | -23.35 | 204.25 | 0.09 | 60.34 | 0.49 | - | ||
| 2019/9 | 18.87 | -21.84 | -9.28 | 186.94 | 3.01 | 64.14 | 0.59 | - | ||
| 2019/8 | 24.15 | 14.39 | 2.02 | 168.07 | 4.6 | 65.49 | 0.58 | - | ||
| 2019/7 | 21.11 | 4.38 | 1.52 | 143.92 | 5.05 | 62.55 | 0.6 | - | ||
| 2019/6 | 20.22 | -4.65 | -2.68 | 122.81 | 5.68 | 62.12 | 0.64 | - | ||
| 2019/5 | 21.21 | 2.56 | 3.36 | 102.58 | 7.5 | 0.0 | N/A | - | ||
| 2019/4 | 20.68 | -1.4 | -0.23 | 81.37 | 8.64 | 0.0 | N/A | - |
| 加權平均股數 YoY | EPS YoY | 本業EPS YoY | 營收 YoY | 毛利率(%) YoY | 營業利益 YoY | 稅前淨利 YoY | 稅後淨利 YoY | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 970 | 0.0 | -0.51 | 0 | -0.24 | 0 | 178.75 | -23.51 | 8.20 | -41.47 | 1.51 | -91.32 | -1.15 | 0 | -4.94 | 0 |
| 2022 (9) | 970 | 0.0 | 0.70 | -80.0 | 0.98 | -70.48 | 233.68 | -5.07 | 14.01 | -50.34 | 17.39 | -66.41 | 14.73 | -72.49 | 6.79 | -80.0 |
| 2021 (8) | 970 | 0.0 | 3.50 | 366.67 | 3.32 | 354.79 | 246.17 | 43.91 | 28.21 | 36.28 | 51.77 | 268.73 | 53.55 | 276.05 | 33.95 | 366.99 |
| 2020 (7) | 970 | 0.0 | 0.75 | -37.5 | 0.73 | -42.52 | 171.06 | -23.19 | 20.70 | 6.54 | 14.04 | -34.7 | 14.24 | -31.87 | 7.27 | -37.76 |
| 2019 (6) | 970 | 35.29 | 1.20 | -71.29 | 1.27 | -59.68 | 222.71 | -8.84 | 19.43 | -27.82 | 21.5 | -53.56 | 20.9 | -54.26 | 11.68 | -60.99 |
| 2018 (5) | 717 | 16.21 | 4.18 | 13.28 | 3.15 | 30.17 | 244.32 | 21.47 | 26.92 | -2.78 | 46.3 | 27.16 | 45.69 | 28.16 | 29.94 | 31.72 |
| 2017 (4) | 617 | 5.11 | 3.69 | 47.6 | 2.42 | 32.97 | 201.14 | 26.59 | 27.69 | -3.72 | 36.41 | 24.05 | 35.65 | 35.14 | 22.73 | 54.52 |
| 2016 (3) | 587 | 0.0 | 2.50 | 72.41 | 1.82 | 73.33 | 158.89 | -5.71 | 28.76 | 32.6 | 29.35 | 40.63 | 26.38 | 37.68 | 14.71 | 72.86 |
| 2015 (2) | 587 | 8.91 | 1.45 | -69.54 | 1.05 | 43.84 | 168.51 | -23.42 | 21.69 | 28.42 | 20.87 | 6.53 | 19.16 | -49.78 | 8.51 | -66.82 |
| 2014 (1) | 539 | 0.0 | 4.76 | 217.33 | 0.73 | -29.13 | 220.05 | 2.16 | 16.89 | 0 | 19.59 | -3.83 | 38.15 | 105.99 | 25.65 | 216.67 |
